Sectors
11
Industries
215
Companies
6,500
Revance Therapeutics
Annual Report 2023
Quarterlytics
Healthcare
Biotechnology
Revance Therapeutics
Annual Report 2023
Your browser does not support PDFs. Please download the report to view it:
Download Annual Report 2023
Download report
Get a demo
More annual reports from
Revance Therapeutics
:
2023 Report
2022 Report
2021 Report
2020 Report
2019 Report
Peers and competitors of Revance Therapeutics:
Albireo Pharma
Acasti Pharma
Otonomy
Regenxbio
Evelo Biosciences, Inc.